Corrigendum to ‟Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulationsˮ [Inform. Med. Unlocked 23 (2021) 1-9/100541]

Subjects

Subjects :

Computer applications to medicine. Medical informatics
R858-859.7

Details

Language :

English

ISSN :

23529148

Volume :

41

Issue :

101263-

Database :

Directory of Open Access Journals

Journal :

Informatics in Medicine Unlocked

Publication Type :

Academic Journal

Accession number :

edsdoj.3a71ab43dc14c119c11c90a9a5c39cd

Document Type :

article

Full Text :

https://doi.org/10.1016/j.imu.2023.101263